Vifor Pharma denies having spread false information about Pharmacosmos

The Swiss firm also reports to be working with the EU Commission as it investigates an alleged smear campaign against Pharmacosmos, a competitor of Vifor Pharma on the iron deficiency drug market.

Photo: Vifor Pharma / PR

Vifor Pharma wants to cooperate with the EU Commission to prove its innocence in the alleged anticompetitive campaign against its Danish competitor, Pharmacosmos, the Swiss firm writes in an emailed response to MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs